Skip to main navigation Skip to search Skip to main content

The effect of antitastamines on the laryngeal chemoreflex

  • Daniel H. Downs
  • , Kerri Johnson
  • , George Goding

Research output: Contribution to journal › Article › peer-review

Abstract

The laryngeal chemoreflex (LCR) consists of apnea, laryngospasm, and cardiovascular changes in neonates after laryngeal irritation and has been implicated in sudden infant death syndrome and pnea of infancy. Antihistamines attenuate a similar vagally mediated pulmonary chemoreflex. The ntravenous antihistamine effect on the LCR was studied in neonatal piglets. Laryngeal muscle activity, espiration, blood pressure, and pulse were measured during water stimulation of the LCR. After aseline LCR recordings, intravenous diphenhydramine (2.5 mg/kg) or cimetidine (20 mg/kg) was olused (control group received saline). LCR measurements were repeated over 7 hours. Diphenhydramine ignificantly shortened apneas (P<.05) 3 to 7 hours after drug bolus, which is believed to be secondary to entral atropinic effects. Cimetidine demonstrated no attenuation of the LCR.

Original languageEnglish (US)
Pages (from-to)857-861
Number of pages5
JournalLaryngoscope
Volume105
Issue number8
DOIs
StatePublished - Aug 1995

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The effect of antitastamines on the laryngeal chemoreflex'. Together they form a unique fingerprint.

Cite this